Skip to main content

India

Riding out the rise

Stakeholders in the Asian recovery have a nervous eye on the region’s central banks for signs as to when interest rates will rise this year – something that could weigh on equity returns and devalue the portfolios of bondholders. Changes in rates…

Hub hubbub

New rules coming into force in many jurisdictions in Asia are challenging the ability of global financial institutions to operate a hub-and-spoke business model for their derivatives businesses. By Jacqueline Low, Jing Gu and Keith Noyes

India finds some forward momentum

The global financial crisis could easily have sounded the death knell for India’s nascent structured products market. But as the country’s equity markets have resumed their upward trend, dealers say equity-linked structures are catching on fast.

China's smoke signal

World leaders will congregate in Copenhagen next month in a bid to thrash out a replacement to the Kyoto protocol for climate change. While the outcome is still far from clear, new policy stances from Asian nations are already having a fundamental effect

Open for hedges

India’s insurance sector has long been hamstrung by its inability to use equity derivatives. This is about to change with the country’s insurance regulator set to relax the rules on derivatives. But are India’s insurers ready for synthetic instruments?…

Open for hedges

India’s insurance sector has long been hamstrung by its inability to use equity derivatives. This is about to change with the country’s insurance regulator set to relax the rules on derivatives. But are India’s insurers ready for synthetic instruments?…

Best in India - Standard Chartered Bank

India's structured products market is still in its infancy, and has been as vulnerable to the fallout from losses on Lehman Brothers Minibonds as most other markets in Asia. Despite these drawbacks, Standard Chartered Bank has stood firm, ramping up…

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here